Albemarle Corporation to Attend Bernstein's 35th Annual Strategic Decisions Conference

CHARLOTTE, N.C., April 30, 2019 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today Luke Kissam, Albemarle CEO, Scott Tozier, Executive Vice President and Chief Financial Officer, David Ryan, Vice President, Corporate Strategy and Investor Relations, and Sharon McGee, Vice President, Investor Relations and Corporate Development, will attend Bernstein's 35^th Annual Strategic Decisions Conference in New York City on Wednesday, May 29. Kissam, Tozier, Ryan and McGee will be available for one-on-one meetings.   

About Albemarle
Albemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics.  Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.

Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 5,400 people and serves customers in approximately 100 countries. We regularly post information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.

View original content to download multimedia:http://www.prnewswire.com/news-releases/albemarle-corporation-to-attend-bernsteins-35th-annual-strategic-decisions-conference-300841338.html

SOURCE Albemarle Corporation